Bankers Trust’s Biogen BIIB Stock Holding History

Bankers Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$218K	Buy	+690	New	+$208K	0.13%	120

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bankers Trust's BIIB Position: Q2 2014 in Review

Bankers Trust opened a new position in Biogen (BIIB) in Q2 2014: 690 shares worth $218K. The stake represents 0.13% of the portfolio and ranks #120 among its holdings.

782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

Bankers Trust held 690 shares of Biogen worth $218K as of Q2 2014.
Biogen was a new Bankers Trust position in Q2 2014.
Biogen made up 0.13% of Bankers Trust's portfolio in Q2 2014, its #120 holding.
782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on Bankers Trust's 13F filing for Q2 2014, filed 15 Aug 2014.